![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rochester Medical Corp. (MM) | NASDAQ:ROCM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.00 | 0 | 01:00:00 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
JONAS DAVID A |
2. Issuer Name
and
Ticker or Trading Symbol
ROCHESTER MEDICAL CORPORATION [ ROCM ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) CFO and Treasurer |
ONE ROCHESTER MEDICAL DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
STEWARTVILLE, MN 55976 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 12/4/2012 | M | 10000 | A | $4.125 | 92500 (1) | D | |||
Common Stock | 12/4/2012 | S | 10000 | D | $10.81 (2) | 82500 (1) | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option (Right to Buy) | $4.125 | 12/4/2012 | M | 10000 | 1/2/2004 (3) | 1/2/2013 | Common Stock | 10000 | $0.00 | 0 | D | ||||
Stock Option (Right to Buy) | $4.625 | 1/2/2005 (3) | 1/2/2014 | Common Stock | 14000 | 14000 | D | ||||||||
Stock Option (Right to Buy) | $4.70 | 1/1/2006 (3) | 1/1/2015 | Common Stock | 40000 | 40000 | D | ||||||||
Stock Option (Right to Buy) | $5.70 | 1/26/2007 | 1/26/2016 | Common Stock | 352 | 352 | D | ||||||||
Stock Option (Right to Buy) | $5.70 | 1/26/2007 (4) | 1/26/2016 | Common Stock | 19648 | 19648 | D | ||||||||
Stock Option (Right to Buy) | $12.30 | 11/21/2007 (3) | 11/21/2016 | Common Stock | 20000 | 20000 | D | ||||||||
Stock Option (Right to Buy) | $11.23 | 2/6/2009 (3) | 2/6/2018 | Common Stock | 20000 | 20000 | D | ||||||||
Stock Option (Right to Buy) | $11.27 | 2/3/2010 (3) | 2/3/2019 | Common Stock | 20000 | 20000 | D | ||||||||
Stock Option (Right to Buy) | $12.27 | 1/28/2011 (3) | 1/28/2020 | Common Stock | 20000 | 20000 | D | ||||||||
Stock Option (Right to Buy) | $10.72 | 1/27/2012 (3) | 1/27/2021 | Common Stock | 20000 | 20000 | D |
Explanation of Responses: | |
( 1) | Includes restricted stock award shares. |
( 2) | The price in Column 4 is a weighted average. The prices actually received ranged from $10.75 to $10.91. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
( 3) | Vest as to 25% annual cumulative installments beginning one year from date of grant, beginning the date shown. |
( 4) | Vest 4,648 shares on 1/26/2007 and annual cummulative installments of 5,000 beginning 1/26/2008. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
JONAS DAVID A
ONE ROCHESTER MEDICAL DRIVE STEWARTVILLE, MN 55976 |
X |
|
CFO and Treasurer |
|
Signatures
|
||
/s/ David A. Jonas | 12/5/2012 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Rochester Medical Corp. (MM) Chart |
1 Month Rochester Medical Corp. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions